1. Home
  2. API vs NNNN Comparison

API vs NNNN Comparison

Compare API & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • API
  • NNNN
  • Stock Information
  • Founded
  • API 2013
  • NNNN 2021
  • Country
  • API United States
  • NNNN Germany
  • Employees
  • API N/A
  • NNNN N/A
  • Industry
  • API Computer Software: Prepackaged Software
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • API Technology
  • NNNN Health Care
  • Exchange
  • API Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • API 354.4M
  • NNNN 369.6M
  • IPO Year
  • API 2020
  • NNNN 2025
  • Fundamental
  • Price
  • API $3.67
  • NNNN $16.10
  • Analyst Decision
  • API Strong Buy
  • NNNN
  • Analyst Count
  • API 1
  • NNNN 0
  • Target Price
  • API $6.00
  • NNNN N/A
  • AVG Volume (30 Days)
  • API 474.9K
  • NNNN 76.2K
  • Earning Date
  • API 08-18-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • API N/A
  • NNNN N/A
  • EPS Growth
  • API N/A
  • NNNN N/A
  • EPS
  • API N/A
  • NNNN 0.06
  • Revenue
  • API $133,504,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • API $7.10
  • NNNN N/A
  • Revenue Next Year
  • API $10.91
  • NNNN N/A
  • P/E Ratio
  • API N/A
  • NNNN $206.03
  • Revenue Growth
  • API N/A
  • NNNN 21.95
  • 52 Week Low
  • API $1.65
  • NNNN $5.18
  • 52 Week High
  • API $6.99
  • NNNN $18.50
  • Technical
  • Relative Strength Index (RSI)
  • API 50.78
  • NNNN N/A
  • Support Level
  • API $3.66
  • NNNN N/A
  • Resistance Level
  • API $3.84
  • NNNN N/A
  • Average True Range (ATR)
  • API 0.14
  • NNNN 0.00
  • MACD
  • API -0.02
  • NNNN 0.00
  • Stochastic Oscillator
  • API 46.87
  • NNNN 0.00

About API Agora Inc.

Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: